Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012 (2012), Article ID 327568, 13 pages
http://dx.doi.org/10.1155/2012/327568
Review Article

Prostaglandin E 𝟐 and the Suppression of Phagocyte Innate Immune Responses in Different Organs

1Department of Biological Sciences, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, 14801-902 São Paulo, SP, Brazil
2Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo (USP), Av Octávio Pinheiro Brisolla 9-75, Bauru, 17012-901 São Paulo, SP, Brazil
3Department of Microbiology and Immunology, Indiana University School of Medicine, 950 West Walnut Street, Indianapolis, IN 46202, USA

Received 15 February 2012; Revised 19 April 2012; Accepted 3 May 2012

Academic Editor: Ruxana Sadikot

Copyright © 2012 Alexandra Medeiros et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. L. Tilley, T. M. Coffman, and B. H. Koller, “Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes,” Journal of Clinical Investigation, vol. 108, no. 1, pp. 15–23, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Subbaramaiah, W. J. Chung, and A. J. Dannenberg, “Ceramide regulates the transcription of cyclooxygenase-2: evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways,” Journal of Biological Chemistry, vol. 273, no. 49, pp. 32943–32949, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. M. M. Monick, P. K. Robeff, N. S. Butler et al., “Phosphatidylinositol 3-kinase activity negatively regulates stability of cyclooxygenase 2 mRNA,” Journal of Biological Chemistry, vol. 277, no. 36, pp. 32992–33000, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. P. J. Jakobsson, S. Thorén, R. Morgenstern, and B. Samuelsson, “Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 13, pp. 7220–7225, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. D. O. Stichtenoth, S. Thorén, H. Bian, M. Peters-Golden, P. J. Jakobsson, and L. J. Crofford, “Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells,” The Journal of Immunology, vol. 167, no. 1, pp. 469–474, 2001. View at Google Scholar · View at Scopus
  6. F. Kojima, H. Naraba, Y. Sasaki, R. Okamoto, T. Koshino, and S. Kawai, “Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells,” Journal of Rheumatology, vol. 29, no. 9, pp. 1836–1842, 2002. View at Google Scholar · View at Scopus
  7. R. M. Breyer, C. K. Bagdassarian, S. A. Myers, and M. D. Breyer, “Prostanoid receptors: subtypes and signaling,” Annual Review of Pharmacology and Toxicology, vol. 41, pp. 661–690, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. A. F. Sheibanie, J. H. Yen, T. Khayrullina et al., “The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23→IL-17 axis,” The Journal of Immunology, vol. 178, no. 12, pp. 8138–8147, 2007. View at Google Scholar · View at Scopus
  9. K. Takayama, G. K. Sukhova, M. T. Chin, and P. Libby, “A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signaling,” Circulation Research, vol. 98, no. 4, pp. 499–504, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. A. I. Medeiros, C. H. Serezani, S. P. Lee, and M. Peters-Golden, “Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling,” The Journal of Experimental Medicine, vol. 206, no. 1, pp. 61–68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. N. Serhan, S. D. Brain, C. D. Buckley et al., “Resolution of inflammation: state of the art, definitions and terms,” The FASEB Journal, vol. 21, no. 2, pp. 325–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Taha, R. Olivenstein, T. Utsumi et al., “Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 2, pp. 636–640, 2000. View at Google Scholar · View at Scopus
  13. S. L. Hempel, M. M. Monick, and G. W. Hunninghake, “Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes,” Journal of Clinical Investigation, vol. 93, no. 1, pp. 391–396, 1994. View at Google Scholar · View at Scopus
  14. R. P. Charbeneau, P. J. Christensen, C. J. Chrisman et al., “Impaired synthesis of prostaglandin E2 by lung fibroblasts and alveolar epithelial cells from GM-CSF−/− mice: implications for fibroproliferation,” American Journal of Physiology Lung Cellular and Molecular Physiology, vol. 284, no. 6, pp. L1103–L1111, 2003. View at Google Scholar
  15. B. B. Moore, M. J. Coffey, P. Christensen et al., “GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism,” The Journal of Immunology, vol. 165, no. 7, pp. 4032–4039, 2000. View at Google Scholar · View at Scopus
  16. M. N. Ballinger, D. M. Aronoff, T. R. McMillan et al., “Critical role of prostaglandin E2 overproduction in impaired pulmonary host response following bone marrow transplantation,” The Journal of Immunology, vol. 177, no. 8, pp. 5499–5508, 2006. View at Google Scholar · View at Scopus
  17. M. Profita, A. Sala, A. Bonanno et al., “Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 298, no. 2, pp. L261–L269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Herrmann, A. Lindemann, J. Gauss, and R. Mertelsmann, “Cytokine-stimulation of prostaglandin synthesis from endogenous and exogenous arachidonic acids in polymorphonuclear leukocytes involving activation and new synthesis of cyclooxygenase,” European Journal of Immunology, vol. 20, no. 11, pp. 2513–2516, 1990. View at Publisher · View at Google Scholar · View at Scopus
  19. D. S. Whittaker, K. S. Bahjat, L. L. Moldawer, and M. J. Clare-Salzler, “Autoregulation of human monocyte-derived dendritic cell maturation and IL-12 production by cyclooxygenase-2-mediated prostanoid production,” The Journal of Immunology, vol. 165, no. 8, pp. 4298–4304, 2000. View at Google Scholar · View at Scopus
  20. A. Lundequist, S. N. Nallamshetty, W. Xing et al., “Prostaglandin E2 exerts homeostatic regulation of pulmonary vascular remodeling in allergic airway inflammation,” The Journal of Immunology, vol. 184, no. 1, pp. 433–441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. G. Harris, J. Padilla, L. Koumas, D. Ray, and R. P. Phipps, “Prostaglandins as modulators of immunity,” Trends in Immunology, vol. 23, no. 3, pp. 144–150, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. S. B. Gordon and R. C. Read, “Macrophage defences against respiratory tract infections,” British Medical Bulletin, vol. 61, pp. 45–61, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. D. M. Aronoff, C. Canetti, and M. Peters-Golden, “Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP,” The Journal of Immunology, vol. 173, no. 1, pp. 559–565, 2004. View at Google Scholar · View at Scopus
  24. M. Monick, J. Glazier, and G. W. Hunninghake, “Human alveolar macrophages suppress interleukin-1 (IL-1) activity via the secretion of prostaglandin E2,” American Review of Respiratory Disease, vol. 135, no. 1, pp. 72–77, 1987. View at Google Scholar · View at Scopus
  25. Y. Sugimoto and S. Narumiya, “Prostaglandin E receptors,” Journal of Biological Chemistry, vol. 282, no. 16, pp. 11613–11617, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. C. H. Serezani, M. N. Ballinger, D. M. Aronoff, and M. Peters-Golden, “Cyclic AMP: master regulator of innate immune cell function,” American Journal of Respiratory Cell and Molecular Biology, vol. 39, no. 2, pp. 127–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Ménard, V. Turmel, and E. Y. Bissonnette, “Serotonin modulates the cytokine network in the lung: Involvement of prostaglandin E2,” Clinical and Experimental Immunology, vol. 150, no. 2, pp. 340–348, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Ratcliffe, A. Walding, P. A. Shelton, A. Flaherty, and I. G. Dougall, “Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages,” European Respiratory Journal, vol. 29, no. 5, pp. 986–994, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. D. M. Aronoff, J. K. Carstens, G. H. Chen, G. B. Toews, and M. Peters-Golden, “Short communication: differences between macrophages and dendritic cells in the cyclic AMP-dependent regulation of lipopolysaccharide-induced cytokine and chemokine synthesis,” Journal of Interferon and Cytokine Research, vol. 26, no. 11, pp. 827–833, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. S. H. Kim, C. H. Serezani, K. Okunishi, Z. Zaslona, D. M. Aronoff, and M. Peters-Golden, “Distinct protein kinase A anchoring proteins direct prostaglandin E2 modulation of toll-like receptor signaling in alveolar macrophages,” Journal of Biological Chemistry, vol. 286, no. 11, pp. 8875–8883, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. C. H. Serezani, J. Chung, M. N. Ballinger, B. B. Moore, D. M. Aronoff, and M. Peters-Golden, “Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase,” American Journal of Respiratory Cell and Molecular Biology, vol. 37, no. 5, pp. 562–570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Canetti, C. H. Serezani, R. G. Atrasz, E. S. White, D. M. Aronoff, and M. Peters-Golden, “Activation of phosphatase and tensin homolog on chromosome 10 mediates the inhibition of FcγR phagocytosis by prostaglandin E2 in alveolar macrophages,” The Journal of Immunology, vol. 179, no. 12, pp. 8350–8356, 2007. View at Google Scholar · View at Scopus
  33. D. M. Aronoff, C. Lewis, C. H. Serezani et al., “E-prostanoid 3 receptor deletion improves pulmonary host defense and protects mice from death in severe Streptococcus pneumoniae infection,” The Journal of Immunology, vol. 183, no. 4, pp. 2642–2649, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. B. W. Christman, J. W. Christman, R. Dworski, I. A. Blair, and C. Prakash, “Prostaglandin E2 limits arachidonic acid availability and inhibits leukotriene B4 synthesis in rat alveolar macrophages by a nonphospholipase A2 mechanism,” The Journal of Immunology, vol. 151, no. 4, pp. 2096–2104, 1993. View at Google Scholar · View at Scopus
  35. K. Sertl, T. Takemura, E. Tschachler, V. J. Ferrans, M. A. Kaliner, and E. M. Shevach, “Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura,” The Journal of Experimental Medicine, vol. 163, no. 2, pp. 436–451, 1986. View at Google Scholar · View at Scopus
  36. E. Vassiliou, H. Jing, and D. Ganea, “Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells,” Cellular Immunology, vol. 223, no. 2, pp. 120–132, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Gonzalez-Juarrero and I. M. Orme, “Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis,” Infection and Immunity, vol. 69, no. 2, pp. 1127–1133, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. M. N. Ballinger, R. Paine III, C. H. C. Serezani et al., “Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa,” American Journal of Respiratory Cell and Molecular Biology, vol. 34, no. 6, pp. 766–774, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Craig, J. Mai, S. Cai, and S. Jeyaseelan, “Neutrophil recruitment to the lungs during bacterial pneumonia,” Infection and Immunity, vol. 77, no. 2, pp. 568–575, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. I. N. Mbawuike and H. B. Herscowitz, “MH-S, a murine alveolar macrophage cell line: morphological, cytochemical, and functional characteristics,” Journal of Leukocyte Biology, vol. 46, no. 2, pp. 119–127, 1989. View at Google Scholar · View at Scopus
  41. M. Joo, Y. S. Hahn, M. Kwon, R. T. Sadikot, T. S. Blackwell, and J. W. Christman, “Hepatitis C virus core protein suppresses NF-κB activation and cyclooxygenase-2 expression by direct interaction with IκB kinase β,” Journal of Virology, vol. 79, no. 12, pp. 7648–7657, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Y. Chen, W. H. Peng, K. D. Tsai, and S. L. Hsu, “Luteolin suppresses inflammation-associated gene expression by blocking NF-κB and AP-1 activation pathway in mouse alveolar macrophages,” Life Sciences, vol. 81, no. 23-24, pp. 1602–1614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Gualde and H. Harizi, “Prostanoids and their receptors that modulate dendritic cell-mediated immunity,” Immunology and Cell Biology, vol. 82, no. 4, pp. 353–360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Boulet, M. Ouellet, K. P. Bateman et al., “Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile,” Journal of Biological Chemistry, vol. 279, no. 22, pp. 23229–23237, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. C. K. Ogle, J. D. Ogle, C. Johnson, L. Keynton, and J. W. Alexander, “The production of C3, PGE2, and TxB2 by splenic, alveolar, and peritoneal guinea pig macrophages,” Prostaglandins, vol. 36, no. 3, pp. 279–289, 1988. View at Google Scholar · View at Scopus
  46. Y. Shibata, J. Gabbard, M. Yamashita et al., “Heat-killed BCG induces biphasic cyclooxygenase 2+ splenic macrophage formation—role of IL-10 and bone marrow precursors,” Journal of Leukocyte Biology, vol. 80, no. 3, pp. 590–598, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Shibata and A. Volkman, “The effect of bone marrow depletion on prostaglandin E-producing suppressor macrophages in mouse spleen,” The Journal of Immunology, vol. 135, no. 6, pp. 3897–3904, 1985. View at Google Scholar · View at Scopus
  48. Y. Shibata, “Restoration of prostaglandin E2-producing splenic macrophages in 89Sr-treated mice with bone marrow from Corynebacterium parvum primed donors,” Regional Immunology, vol. 2, no. 3, pp. 169–175, 1989. View at Google Scholar · View at Scopus
  49. N. Bilyk and P. G. Holt, “Cytokine modulation of the immunosuppressive phenotype of pulmonary alveolar macrophage populations,” Immunology, vol. 86, no. 2, pp. 231–237, 1995. View at Google Scholar · View at Scopus
  50. H. Harizi and N. Gualde, “Eicosanoids: an emerging role in dendritic cell biology,” Archivum Immunologiae et Therapiae Experimentalis, vol. 52, no. 1, pp. 1–5, 2004. View at Google Scholar · View at Scopus
  51. H. Harizi, C. Grosset, and N. Gualde, “Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes,” Journal of Leukocyte Biology, vol. 73, no. 6, pp. 756–763, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Harizi and N. Gualde, “Dendritic cells produce eicosanoids, which modulate generation and functions of antigen-presenting cells,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 66, no. 5-6, pp. 459–466, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Shibata, A. Nishiyama, H. Ohata, J. Gabbard, Q. N. Myrvik, and R. A. Henriksen, “Differential effects of IL-10 on prostaglandin H synthase-2 expression and prostaglandin E2 biosynthesis between spleen and bone marrow macrophages,” Journal of Leukocyte Biology, vol. 77, no. 4, pp. 544–551, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Betz and B. S. Fox, “Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines,” The Journal of Immunology, vol. 146, no. 1, pp. 108–113, 1991. View at Google Scholar · View at Scopus
  55. K. K. Meja, P. J. Barnes, and M. A. Giembycz, “Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-α generation,” British Journal of Pharmacology, vol. 122, no. 1, pp. 149–157, 1997. View at Publisher · View at Google Scholar · View at Scopus
  56. H. P. Lemos, R. Grespan, S. M. Vieira et al., “Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNγ production,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5954–5959, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Chizzolini, R. Chicheportiche, M. Alvarez et al., “Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion,” Blood, vol. 112, no. 9, pp. 3696–3703, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Suda, N. Takahashi, and T. J. Martin, “Modulation of osteoclast differentiation,” Endocrine Reviews, vol. 13, no. 1, pp. 66–80, 1992. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Kobayashi, I. Take, T. Yamashita et al., “Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors,” Journal of Biological Chemistry, vol. 280, no. 25, pp. 24035–24042, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. K. J. Ibbotson, G. D. Roodman, L. M. McManus, and G. R. Mundy, “Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells,” Journal of Cell Biology, vol. 99, no. 2, pp. 471–480, 1984. View at Google Scholar · View at Scopus
  61. T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin, “Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families,” Endocrine Reviews, vol. 20, no. 3, pp. 345–357, 1999. View at Google Scholar · View at Scopus
  62. Y. Y. Kong, H. Yoshida, I. Sarosi et al., “OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis,” Nature, vol. 397, no. 6717, pp. 315–323, 1999. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Y. Han, N. K. Lee, K. H. Kim et al., “Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis,” Blood, vol. 106, no. 4, pp. 1240–1245, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. I. Suponitzky and M. Weinreb, “Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae,” Journal of Endocrinology, vol. 156, no. 1, pp. 51–57, 1998. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Mano, T. Arakawa, H. Mano et al., “Prostaglandin E2 directly inhibits bone-resorbing activity of isolated mature osteoclasts mainly through the EP4 receptor,” Calcified Tissue International, vol. 67, no. 1, pp. 85–92, 2000. View at Google Scholar · View at Scopus
  66. T. Suzawa, C. Miyaura, M. Inada et al., “The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs,” Endocrinology, vol. 141, no. 4, pp. 1554–1559, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. F. González-Scarano and G. Baltuch, “Microglia as mediators of inflammatory and degenerative diseases,” Annual Review of Neuroscience, vol. 22, pp. 219–240, 1999. View at Publisher · View at Google Scholar · View at Scopus
  68. J. B. Leslie and W. D. Watkins, “Eicosanoids in the central nervous system,” Journal of Neurosurgery, vol. 63, no. 5, pp. 659–668, 1985. View at Google Scholar · View at Scopus
  69. K. Yamagata, K. I. Andreasson, W. E. Kaufmann, C. A. Barnes, and P. F. Worley, “Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids,” Neuron, vol. 11, no. 2, pp. 371–386, 1993. View at Google Scholar · View at Scopus
  70. N. V. Chandrasekharan, H. Dai, K. L. T. Roos et al., “COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 21, pp. 13926–13931, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. J. E. Dinchuk, R. Q. Liu, and J. M. Trzaskos, “COX-3: in the wrong frame in mind,” Immunology Letters, vol. 86, no. 1, p. 121, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. B. Kis, J. A. Snipes, T. Gaspar, G. Lenzser, C. D. Tulbert, and D. W. Busija, “Cloning of cyclooxygenase-1b (putative COX-3) in mouse,” Inflammation Research, vol. 55, no. 7, pp. 274–278, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. M. K. O'Banion, “Prostaglandin E2 synthases in neurologic homeostasis and disease,” Prostaglandins and Other Lipid Mediators, vol. 91, no. 3-4, pp. 113–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Vazquez-Tello, L. Fan, X. Hou et al., “Intracellular-specific colocalization of prostaglandin E2 synthases and cyclooxygenases in the brain,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 287, no. 5, pp. R1155–R1163, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Seregi, M. Keller, R. Jackisch, and G. Hertting, “Comparison of the prostanoid synthesizing capacity in homogenates from primary neuronal and astroglial cell cultures,” Biochemical Pharmacology, vol. 33, no. 20, pp. 3315–3318, 1984. View at Publisher · View at Google Scholar · View at Scopus
  76. L. Minghetti and G. Levi, “Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures,” Journal of Neurochemistry, vol. 65, no. 6, pp. 2690–2698, 1995. View at Google Scholar · View at Scopus
  77. L. Minghetti and G. Levi, “Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide,” Progress in Neurobiology, vol. 54, no. 1, pp. 99–125, 1998. View at Publisher · View at Google Scholar · View at Scopus
  78. Y. Ikeda-Matsuo, Y. Ikegaya, N. Matsuki, S. Uematsu, S. Akira, and Y. Sasaki, “Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production,” Journal of Neurochemistry, vol. 94, no. 6, pp. 1546–1558, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. L. Minghetti, E. Polazzi, A. Nicolini, and G. Levi, “Opposite regulation of prostaglandin E2 synthesis by transforming growth factor-β1 and interleukin 10 in activated microglial cultures,” Journal of Neuroimmunology, vol. 82, no. 1, pp. 31–39, 1998. View at Publisher · View at Google Scholar · View at Scopus
  80. G. Levi, L. Minghetti, and F. Aloisi, “Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions,” Biochimie, vol. 80, no. 11, pp. 899–904, 1998. View at Publisher · View at Google Scholar · View at Scopus
  81. J. C. M. Schlachetzki, B. L. Fiebich, E. Haake et al., “Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia,” Journal of Neuroinflammation, vol. 7, article 2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. L. Minghetti, E. Polazzi, A. Nicolini, C. Creminon, and G. Levi, “Up-regulatipn of cyclooxygenase-2 expression in cultured microglia by prostaglandin E2, cyclic AMP and non-steroidal anti-inflammatory drugs,” European Journal of Neuroscience, vol. 9, no. 5, pp. 934–940, 1997. View at Google Scholar · View at Scopus
  83. L. Minghetti, E. Polazzi, A. Nicolini, C. Créminon, and G. Levi, “Interferon-γ and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression,” Journal of Neurochemistry, vol. 66, no. 5, pp. 1963–1970, 1996. View at Google Scholar · View at Scopus
  84. L. Minghetti, A. Nicolini, E. Polazzi et al., “Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocartin 1,” British Journal of Pharmacology, vol. 126, no. 6, pp. 1307–1314, 1999. View at Google Scholar · View at Scopus
  85. J. Zhang, S. Fujii, Z. Wu et al., “Involvement of COX-1 and up-regulated prostaglandin e synthases in phosphatidylserine liposome-induced prostaglandin E2 production by microglia,” Journal of Neuroimmunology, vol. 172, no. 1-2, pp. 112–120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. F. Aloisi, R. de Simone, S. Columba-Cabezas, and G. Levi, “Opposite effects of interferon-gamma and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities,” Journal of Neuroscience Research, vol. 56, no. 6, pp. 571–580.
  87. F. Aloisi, G. Penna, J. Cerase, B. Menendez Iglesias, and L. Adorini, “IL-12 production by central nervous system microglia is inhibited by astrocytes,” The Journal of Immunology, vol. 159, no. 4, pp. 1604–1612, 1997. View at Google Scholar · View at Scopus
  88. K. Suk, S. Yeou Kim, and H. Kim, “Regulation of IL-18 production by IFNγ and PGE2 in mouse microglial cells: involvement of NF-kB pathway in the regulatory processes,” Immunology Letters, vol. 77, no. 2, pp. 79–85, 2001. View at Publisher · View at Google Scholar · View at Scopus
  89. B. M. Iglesias, J. Cerase, C. Ceracchini, G. Levi, and F. Aloisi, “Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-γ and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents,” Journal of Neuroimmunology, vol. 72, no. 1, pp. 83–93, 1997. View at Publisher · View at Google Scholar · View at Scopus
  90. R. Mittal, I. Gonzalez-Gomez, A. Panigrahy, K. Goth, R. Bonnet, and N. V. Prasadarao, “IL-10 administration reduces PGE2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitis,” The Journal of Experimental Medicine, vol. 207, no. 6, pp. 1307–1319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Rivest, “What is the cellular source of prostaglandins in the brain in response to systemic inflammation? Facts and controversies,” Molecular Psychiatry, vol. 4, no. 6, pp. 501–507, 1999. View at Google Scholar · View at Scopus
  92. A. Nadjar, J. Sauvant, C. Combe, P. Parnet, and J. P. Konsman, “Brain cyclooxygenase-2 mediates interleukin-1-induced cellular activation in preoptic and arcuate hypothalamus, but not sickness symptoms,” Neurobiology of Disease, vol. 39, no. 3, pp. 393–401, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Guay, K. Bateman, R. Gordon, J. Mancini, and D. Riendeau, “Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1,” Journal of Biological Chemistry, vol. 279, no. 23, pp. 24866–24872, 2004. View at Publisher · View at Google Scholar · View at Scopus
  94. H. Yang and C. Chen, “Cyclooxygenase-2 in synaptic signaling,” Current Pharmaceutical Design, vol. 14, no. 14, pp. 1443–1451, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. D. Milatovic, T. J. Montine, and M. Aschner, “Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity,” NeuroToxicology, vol. 32, no. 3, pp. 312–319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. K. Andreasson, “Emerging roles of PGE2 receptors in models of neurological disease,” Prostaglandins and Other Lipid Mediators, vol. 91, no. 3-4, pp. 104–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. F. S. Shie, K. S. Montine, R. M. Breyer, and T. J. Montine, “Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity,” GLIA, vol. 52, no. 1, pp. 70–77, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. J. Shi, J. Johansson, N. S. Woodling, Q. Wang, T. J. Montine, and K. Andreasson, “The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity,” The Journal of Immunology, vol. 184, no. 12, pp. 7207–7218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. T. Nagamatsu and D. J. Schust, “Review: the immunomodulatory roles of macrophages at the maternal-fetal interface,” Reproductive Sciences, vol. 17, no. 3, pp. 209–218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. W. Liu, S. Dubinett, S. L. A. Patterson, and K. A. Kelly, “COX-2 inhibition affects growth rate of Chlamydia muridarum within epithelial cells,” Microbes and Infection, vol. 8, no. 2, pp. 478–486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. D. M. Aronoff, Y. Hao, J. Chung et al., “Misoprostol impairs female reproductive tract innate immunity against Clostridium sordellii,” The Journal of Immunology, vol. 180, no. 12, pp. 8222–8230, 2008. View at Google Scholar · View at Scopus
  102. C. Shannon, L. P. Brothers, N. M. Philip, and B. Winikoff, “Infection after medical abortion: a review of the literature,” Contraception, vol. 70, no. 3, pp. 183–190, 2004. View at Publisher · View at Google Scholar · View at Scopus
  103. R. Ikegami, Y. Sugimoto, E. Segi et al., “The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages,” The Journal of Immunology, vol. 166, no. 7, pp. 4689–4696, 2001. View at Google Scholar · View at Scopus
  104. J. Wilborn, D. L. DeWitt, and M. Peters-Golden, “Expression and role of cyclooxygenase isoforms in alveolar and peritoneal macrophages,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 268, no. 2, pp. L294–L301, 1995. View at Google Scholar · View at Scopus
  105. S. L. Kunkel, R. C. Wiggins, S. W. Chensue, and J. Larrick, “Regulation of macrophage tumor necrosis factor production by prostaglandin E2,” Biochemical and Biophysical Research Communications, vol. 137, no. 1, pp. 404–410, 1986. View at Google Scholar · View at Scopus
  106. G. Strassmann, V. Patil-Koota, F. Finkelman, M. Fong, and T. Kambayashi, “Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2,” The Journal of Experimental Medicine, vol. 180, no. 6, pp. 2365–2370, 1994. View at Publisher · View at Google Scholar · View at Scopus
  107. H. Iwahashi, A. Takeshita, and S. Hanazawa, “Prostaglandin E2 stimulates AP-1-mediated CD14 expression in mouse macrophages via cyclic AMP-dependent protein kinase A,” The Journal of Immunology, vol. 164, no. 10, pp. 5403–5408, 2000. View at Google Scholar · View at Scopus
  108. L. J. Marnett, T. L. Wright, B. C. Crews, S. R. Tannenbaum, and J. D. Morrow, “Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase,” Journal of Biological Chemistry, vol. 275, no. 18, pp. 13427–13430, 2000. View at Publisher · View at Google Scholar · View at Scopus
  109. E. Kuroda and U. Yamashita, “Mechanisms of enhanced macrophage-mediated prostaglandin E2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice,” The Journal of Immunology, vol. 170, no. 2, pp. 757–764, 2003. View at Google Scholar · View at Scopus
  110. T. Tajima, T. Murata, K. Aritake et al., “Lipopolysaccharide induces macrophage migration via prostaglandin D2 and prostaglandin E2,” Journal of Pharmacology and Experimental Therapeutics, vol. 326, no. 2, pp. 493–501, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. N. E. Hubbard, S. H. Lee, D. Lim, and K. L. Erickson, “Differential mRNA expression of prostaglandin receptor subtypes in macrophage activation,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 65, no. 5-6, pp. 287–294, 2001. View at Publisher · View at Google Scholar · View at Scopus
  112. Z. F. Huang, J. B. Massey, and D. P. Via, “Differential regulation of cyclooxygenase-2 (COX-2) mRNA stability by interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in human in vitro differentiated macrophages,” Biochemical Pharmacology, vol. 59, no. 2, pp. 187–194, 2000. View at Publisher · View at Google Scholar · View at Scopus
  113. J. C. G. Blanco, C. Contursi, C. A. Salkowski, D. L. DeWitt, K. Ozato, and S. N. Vogel, “Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon γ- dependent cyclooxygenase 2 expression,” The Journal of Experimental Medicine, vol. 191, no. 12, pp. 2131–2144, 2000. View at Publisher · View at Google Scholar · View at Scopus
  114. V. Vila-Del Sol and M. Fresno, “Involvement of TNF and NF-κB in the transcriptional control of cyclooxygenase-2 expression by IFN-γ in macrophages,” The Journal of Immunology, vol. 174, no. 5, pp. 2825–2833, 2005. View at Google Scholar · View at Scopus
  115. B. Hinz, K. Brune, and A. Pahl, “Prostaglandin E2 upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages,” Biochemical and Biophysical Research Communications, vol. 272, no. 3, pp. 744–748, 2000. View at Publisher · View at Google Scholar · View at Scopus
  116. T. Hattori, M. Pack, P. Bougnoux, P. Bougnoux, Z. L. Chang, and T. Hoffman, “Interferon-induced differentiation of U937 cells. Comparison with other agents that promote differentiation of human myeloid or monocytelike cell lines,” Journal of Clinical Investigation, vol. 72, no. 1, pp. 237–244, 1983. View at Google Scholar · View at Scopus
  117. K. Mori, I. Tanaka, M. Kotani et al., “Gene expression of the human prostaglandin E receptor EP4 subtype: differential regulation in monocytoid and lymphoid lineage cells by phorbol ester,” Journal of Molecular Medicine, vol. 74, no. 6, pp. 333–336, 1996. View at Publisher · View at Google Scholar · View at Scopus
  118. L. Zeng, S. An, and E. J. Goetzl, “Independent down-regulation of EP2 and EP3 subtypes of the prostaglandin E2 receptors on U937 human monocytic cells,” Immunology, vol. 86, no. 4, pp. 620–628, 1995. View at Google Scholar · View at Scopus
  119. H. K. Tay and A. J. Melendez, “FcγRI-triggered generation of arachidonic acid and eicosanoids requires iPLA2 but not cPLA2 in human monocytic cells,” Journal of Biological Chemistry, vol. 279, no. 21, pp. 22505–22513, 2004. View at Publisher · View at Google Scholar · View at Scopus
  120. P. S. Penglis, L. G. Cleland, M. Demasi, G. E. Caughey, and M. J. James, “Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors,” The Journal of Immunology, vol. 165, no. 3, pp. 1605–1611, 2000. View at Google Scholar · View at Scopus
  121. M. Barrios-Rodiles, G. Tiraloche, and K. Chadee, “Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL- 1β and TNF-α,” The Journal of Immunology, vol. 163, no. 2, pp. 963–969, 1999. View at Google Scholar · View at Scopus
  122. S. J. Cayeux, P. C. L. Beverley, R. Schulz, and B. Dorken, “Elevated plasma prostaglandin E2 levels found in 14 patients undergoing autologous bone marrow or stem cell transplantation,” Bone Marrow Transplantation, vol. 12, no. 6, pp. 603–608, 1993. View at Google Scholar · View at Scopus
  123. N. Longo, J. M. Zabay, J. M. Sempere, J. Navarro, and E. Fernandez-Cruz, “Altered production of PGE2, IL-1β and TNF-α by peripheral blood monocytes from HIV-positive individuals at early stages of HIV infection,” Journal of Acquired Immune Deficiency Syndromes, vol. 6, no. 9, pp. 1017–1023, 1993. View at Google Scholar · View at Scopus
  124. P. P. Stapleton, J. Fujita, E. M. Murphy, H. A. Naama, and J. M. Daly, “The influence of restricted calorie intake on peritoneal macrophage function,” Nutrition, vol. 17, no. 1, pp. 41–45, 2001. View at Publisher · View at Google Scholar · View at Scopus
  125. M. G. Hayek, C. Mura, D. Wu et al., “Enhanced expression of inducible cyclooxygenase with age in murine macrophages,” The Journal of Immunology, vol. 159, no. 5, pp. 2445–2451, 1997. View at Google Scholar · View at Scopus
  126. M. Starczewski, R. Voigtmann, B. A. Peskar, and B. M. Peskar, “Plasma levels of 15-keto-13,14-dihydro-prostaglandin E2 in patients with bronchogenic carcinoma,” Prostaglandins Leukotrienes and Medicine, vol. 13, no. 3, pp. 249–258, 1984. View at Google Scholar · View at Scopus
  127. B. Strandvik, E. Svensson, and H. W. Seyberth, “Prostanoid biosynthesis in patients with cystic fibrosis,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 55, no. 6, pp. 419–425, 1996. View at Publisher · View at Google Scholar · View at Scopus
  128. A. B. Bjornson, R. W. Knippenberg, and H. S. Bjornson, “Nonsteroidal anti-inflammatory drugs correct the bactericidal defect of polymorphonuclear leukocytes in a guinea pig model of thermal injury,” Journal of Infectious Diseases, vol. 157, no. 5, pp. 959–967, 1988. View at Google Scholar · View at Scopus